Lead sponsor
Texas Tech University
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
2
Trials led
1
Ongoing
173
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
2
Trials by status
Recruiting
1
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue ReactivityBMI 30-50not applicableCompleted73